| |
Minimum |
Maximum |
Mean |
SD |
| Age (years) |
17 |
63 |
35.26 |
9.2 |
| CD4+ |
9 |
82 |
29.26 |
14.07 |
| Gender |
No. |
% |
| Female |
9 |
9.4 |
| Male |
87 |
90.6 |
| Time since HIV diagnosis |
| <1 month |
90 |
93.8 |
| 1-6 months |
1 |
1.0 |
| 6 months-1 year |
5 |
5.2 |
| Antimicrobial use prior to taking specimens for diagnosis of candidiasis |
| Yes |
5 |
5.2 |
| No |
91 |
94.8 |
| ARV treatment |
| Without ARV |
96 |
100 |
| With ARV |
0 |
0 |
| HIV/AIDS and comorbidity |
| Without apparent associated pathology |
75 |
78.1 |
| Viral hepatitis B-C |
6 |
6.3 |
| Latent syphilis |
2 |
2.1 |
| Pulmonary pneumocystis |
4 |
4.2 |
| Disseminated tuberculosis |
3 |
3.1 |
| Hodgkin’s neoplasm |
5 |
5.2 |
| Encephalitis due to Toxoplasma gondii |
1 |
1 |
|
